Reference of 2213-63-0, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a article，once mentioned of 2213-63-0
Heterocyclic systems containing bridgehead nitrogen atom: Synthesis and evaluation of biological activity of imidazo[2,1-b]-1,3,4-thiadiazolo [2,3-c]-s-triazoles, s-Triazolo[3,4-b]-1,3,4-thiadiazolo[3,2-b]imidazo[4,5-b] quinoxaline and bis-(s-Triazolo[3,4-b]-1,3,4-thiadiazolo[3,2-b][imidazo[4,5-b]- cyclohexane]-5a,6a-diene)
Condensation of 4-amino-5-mercapto-3-(alpha-naphthyl)-s-triazole (1) with cyanogen bromide gives 6-amino-3-(alpha-naphthyl)-s-triazolo[3,4-b]-1,3,4- thiadiazole (2) which on condensation with chloranil yields 3,9-di-(alpha- naphthyl)-6,14- dioxo-bis-(s-triazolo[3,4-b]-1,3,4-thiadiazolo[3,2-b]imidazo[4, 5-b]cyclohexane]-5a,6a-diene) (3). 3-(alpha-naphthyl)- s-triazolo[3,4-b]-1,3, 4-thiadiazolo[3,2-b]imidazo[4,5-b]quinoxaline (4) is obtained by a similar condensation of (2) with 2,3-dichloroquinoxaline. The reaction of (2) with a-haloketones followed by bromination affords 7-aryl-3-(alpha- naphthyl)-imidazo[2,1-b]-1,3,4-thiadiazolo[2,3-c]-s-triazoles (5) and their 6-bromo analogues 6 respectively. The structures of all newly synthesized compounds were established on the basis of elemental analyses, IR, 1H-NMR. The antibacterial and antifungal activities of all newly synthesized compounds have also been evaluated.
A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 2213-63-0
Reference：
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1418 | ChemSpider